Stock Events

Stock Events

Protalix BioTherapeutics (PLX) Q2 2026 Earnings

13MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.05

0.04

0.13

0.22

Details

Expected EPS

-0.01

Actual EPS

0.22

Surprise EPS

0.23

Surprise Percent

+2,300%

Description

Protalix BioTherapeutics (PLX) has reported earnings of 0.22 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.